Cargando…
Combined Pharmacotherapy with Alendronate and Desferoxamine Regulate the Bone Resorption and Bone Regeneration for Preventing Glucocorticoids-Induced Osteonecrosis of the Femoral Head
BACKGROUND: Osteonecrosis of the femoral head (ONFH) is a challenge for surgeons and is still without effective treatment method. This study is aimed at evaluating the combined pharmacotherapy with alendronate and desferoxamine for preventing glucocorticoid-induced osteonecrosis of the femoral head...
Autores principales: | Sheng, Hongfeng, Lao, Yangjun, Zhang, Shuliang, Ding, Weiguo, Lu, Di, Xu, Bin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7532397/ https://www.ncbi.nlm.nih.gov/pubmed/33029500 http://dx.doi.org/10.1155/2020/3120458 |
Ejemplares similares
-
Administration of erythropoietin prevents bone loss in osteonecrosis of the femoral head in mice
por: Xu, Taotao, et al.
Publicado: (2017) -
Less sclerotic microarchitecture pattern with increased bone resorption in glucocorticoid-associated osteonecrosis of femoral head as compared to alcohol-associated osteonecrosis of femoral head
por: Chen, Yiwei, et al.
Publicado: (2023) -
Three‐Dimensional Distribution of Bone‐Resorption Lesions in Osteonecrosis of the Femoral Head Based on the Three‐Pillar Classification
por: Liu, Guang‐bo, et al.
Publicado: (2021) -
Efficacy of Alendronate for Preventing Collapse of Femoral Head in Adult Patients with Nontraumatic Osteonecrosis
por: Hong, Yu-Cai, et al.
Publicado: (2014) -
Polarization Behavior of Bone Macrophage as Well as Associated Osteoimmunity in Glucocorticoid-Induced Osteonecrosis of the Femoral Head
por: Zhang, Qingyu, et al.
Publicado: (2023)